Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Non Alcoholic Fatty Liver Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Non Alcoholic Fatty Liver Disease Treatmentmarket, defines the market attractiveness level of Non Alcoholic Fatty Liver Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Non Alcoholic Fatty Liver Disease Treatment industry, describes the types of Non Alcoholic Fatty Liver Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non Alcoholic Fatty Liver Disease Treatment market and the development prospects and opportunities of Non Alcoholic Fatty Liver Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non Alcoholic Fatty Liver Disease Treatment market in Chapter 13.
By Player:
Allergan
Pfizer
Daewoong
Takeda Pharmaceutical
Roche
Merck
Novartis
Limerick BioPharma
GW Pharmaceuticals
AstraZeneca
Gilead Sciences
Cardax
By Type:
Antioxidants
Thiazolidinedione
Biguanides
Lipid lowering Agents
FXR Receptor Agonist
Others
By End-User:
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Non Alcoholic Fatty Liver Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Non Alcoholic Fatty Liver Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Non Alcoholic Fatty Liver Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Non Alcoholic Fatty Liver Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Non Alcoholic Fatty Liver Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
-
7.2 United States Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
-
7.3 Europe Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
-
7.4 China Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
-
7.5 Japan Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
-
7.6 India Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Non Alcoholic Fatty Liver Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Non Alcoholic Fatty Liver Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast (2022-2028)
9 Global Non Alcoholic Fatty Liver Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antioxidants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Thiazolidinedione Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Biguanides Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Lipid lowering Agents Consumption and Growth Rate (2017-2022)
-
9.1.5 Global FXR Receptor Agonist Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Non Alcoholic Fatty Liver Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antioxidants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Thiazolidinedione Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Lipid lowering Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global FXR Receptor Agonist Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Non Alcoholic Fatty Liver Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Non Alcoholic Fatty Liver Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Non Alcoholic Fatty Liver Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Non Alcoholic Fatty Liver Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Non Alcoholic Fatty Liver Disease Treatment Market Competitive Analysis
-
14.1 Allergan
-
14.1.1 Allergan Company Details
-
14.1.2 Allergan Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.3 Daewoong
-
14.3.1 Daewoong Company Details
-
14.3.2 Daewoong Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Daewoong Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.4 Takeda Pharmaceutical
-
14.4.1 Takeda Pharmaceutical Company Details
-
14.4.2 Takeda Pharmaceutical Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Takeda Pharmaceutical Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.8 Limerick BioPharma
-
14.8.1 Limerick BioPharma Company Details
-
14.8.2 Limerick BioPharma Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Limerick BioPharma Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.9 GW Pharmaceuticals
-
14.9.1 GW Pharmaceuticals Company Details
-
14.9.2 GW Pharmaceuticals Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GW Pharmaceuticals Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Details
-
14.10.2 AstraZeneca Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.11 Gilead Sciences
-
14.11.1 Gilead Sciences Company Details
-
14.11.2 Gilead Sciences Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Gilead Sciences Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
14.12 Cardax
-
14.12.1 Cardax Company Details
-
14.12.2 Cardax Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Cardax Non Alcoholic Fatty Liver Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Non Alcoholic Fatty Liver Disease Treatment
-
Figure Non Alcoholic Fatty Liver Disease Treatment Picture
-
Table Global Non Alcoholic Fatty Liver Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Non Alcoholic Fatty Liver Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Non Alcoholic Fatty Liver Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Non Alcoholic Fatty Liver Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Non Alcoholic Fatty Liver Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Non Alcoholic Fatty Liver Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antioxidants Consumption and Growth Rate (2017-2022)
-
Figure Global Thiazolidinedione Consumption and Growth Rate (2017-2022)
-
Figure Global Biguanides Consumption and Growth Rate (2017-2022)
-
Figure Global Lipid lowering Agents Consumption and Growth Rate (2017-2022)
-
Figure Global FXR Receptor Agonist Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antioxidants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thiazolidinedione Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lipid lowering Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FXR Receptor Agonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Non Alcoholic Fatty Liver Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Non Alcoholic Fatty Liver Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Daewoong (Foundation Year, Company Profile and etc.)
-
Table Daewoong Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daewoong Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Limerick BioPharma (Foundation Year, Company Profile and etc.)
-
Table Limerick BioPharma Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Limerick BioPharma Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table GW Pharmaceuticals Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GW Pharmaceuticals Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
Table Cardax (Foundation Year, Company Profile and etc.)
-
Table Cardax Non Alcoholic Fatty Liver Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardax Non Alcoholic Fatty Liver Disease Treatment Product and Service
-
